Cite
HARVARD Citation
Kattakuzhy, S. et al. (n.d.). P-B4 Predictors of sustained viral response to 4–6 week duration therapy with Ledipasvir + Sofosbuvir + Gs-9451 +/− Gs-9669 in early and advanced fibrosis (Nih-Ihv synergy trial). Journal of acquired immune deficiency syndromes. p. . [Online].